A Perfused Vein Preparation Sensitive to Plasma Kinins

  • J. D. Horowitz
  • M. L. Mashford


The isolated perfused central vein of the rabbit ear constricts in response to approximately 0.5 ng of BK or kallidin injected into the perfusion flow of 10 ml/min. Constrictor responses are also elicited by several other substances including catecholamines and histamine but none approach the potency of the plasma kinins. This relative specificity together with the steep dose-response curve for kinins makes it an eminently suitable preparation for bioassay of these peptides. Rabbit veins from other sites do not have the same pattern of reactivity and no generalization is possible from these data to veins in vivo.


Veins Plasma Kinins. 


Venen Plasmakinin. 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bobbin, R.P., and P.S. Guth: Venoconstrictive action of bradykinin. J. Pharmacol. exp. Ther. 160, 11–21 (1968).Google Scholar
  2. Chou, C. C, E.D. Frohlich, and E.C. Texter Jr.: A comparative study of the effects of bradykinin, kallidin II and eledoisin on segmental superior mesenteric resistance. J. Physiol. (Lond.) 176, 1–11 (1965).Google Scholar
  3. de la Lande, I.S., and M.J. Rand: A simple isolated nerve-blood vessel preparation. Aust. J. exp. Biol. med. Sci. 43, 639–656 (19PubMedCrossRefGoogle Scholar
  4. Florey, H.W., and H.M. Carleton: Rouget cells and their functions. Proc. roy. Soc. B 100, 23–31 (1926).CrossRefGoogle Scholar
  5. Greeff, K., u. E. Moog: Vergleichende Untersuchungen über die Bronchoconstric-torische Wirkung des Bradykinin, Histamins und Serotonins an isolierten Lungen präparation. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 248, 204–215 (1964).Google Scholar
  6. Guth, P.S., R. Bobbin, G. Cano, and J. Amaro: Venoconstriction induced by bradykinin in the intact and denervated rabbit ear. Fed. Proc. 25, 287 (1966).Google Scholar
  7. — G. Cano, and J. Jaramillo: The effect of bradykinin on vascular smooth muscle. Ann. N.Y. Acad. Sci. 104, 69–76 (1963).PubMedCrossRefGoogle Scholar
  8. Horowitz, J.D., and M.L. Mashford: Vasoactivity of human plasma and plasma protein fractions. Experientia (Basel) 24, 1126 (1968).CrossRefGoogle Scholar
  9. Klupp, H., u. H. Konzett: Der Einfluß von Bradykinin und Kallidin auf dem Druck in der Arteria pulmonalis. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 249, 479–485 (1965).CrossRefGoogle Scholar
  10. Rowley, D.A.: Venous constriction as the cause of increased vascular permeability produced by 5-hydroxytryptamine, histamine, bradykinin and 48/80 in the rat. Brit. J. exp. Path. 45, 56–67 (1964).PubMedGoogle Scholar
  11. Sakuma, A., and S. Oh-Ishi: Tranexamic acid enhances bradykinin induced venoconstriction. Jap. J. Pharmacol. 16, 485–486 (1966).PubMedCrossRefGoogle Scholar
  12. Wiegershausen, B., u. G. Hennighausen: Gefäßkonstriktion durch synthetisches Bradykinin und ihre pharmakologische Beeinflußbarkeit. Experientia (Basel) 22, 234–235 (1966).CrossRefGoogle Scholar
  13. Zacest, R., and M.L. Mashford: Blood bradykinin levels in the human. Aust. J. exp. Biol. med. Sci. 45, 89–95 (1967).PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1969

Authors and Affiliations

  • J. D. Horowitz
    • 1
  • M. L. Mashford
    • 1
    • 2
  1. 1.Department of Human Physiology and PharmacologyUniversity of AdelaideSouth Australia
  2. 2.Department of Medicine Austin Hospital HeidelbergUniversity of MelbourneAustralia

Personalised recommendations